How Much Does Tirzepatide Cost? A Year Under Three Ways of Paying
Compounded tirzepatide at ACT 2 Health costs $399 a month as a weekly injection or $399 a month as a daily capsule, and that price covers both the clinician's care and the medication. Buying the injection as a 3-month package ($1,125) or a 6-month package ($2,199) brings it down to $375 or $367 a month.
This page covers the cost only. Whether tirzepatide suits you is covered on the tirzepatide injection page and the medical weight loss page; every ACT 2 price is on pricing.
What does tirzepatide cost at ACT 2?
| Treatment | Option | Price | How it is billed |
|---|---|---|---|
| Tirzepatide Injection | 1 month | $399 | Monthly |
| 3 months | $1,125 | Once for 3 months ($375/month) | |
| 6 months | $2,199 | Once for 6 months ($367/month) | |
| Tirzepatide Oral Capsules | 1 month | $399 | Monthly |
| Weight Loss Program Membership | 1 month | $75 | Monthly |
What the price includes. The clinical care and the compounded medication, dispensed and shipped by a licensed pharmacy, with no separate pharmacy bill and no membership fee. The assessment and eligibility review are free; you pay only if a clinician finds tirzepatide appropriate and you go ahead.
What it does not include. Lab work: the program starts from a baseline, and the comprehensive panel is $199, charged once. Shipping and taxes, where they apply, are shown before you pay.
What does not change it. The dose. Your clinician increases it over the first months, and the price stays the same at every step. Nor does your state: the price is the same everywhere we practice.
The oral tirzepatide capsule is sold monthly only; only the injection has packages. The third line in the table is not tirzepatide; it is covered in the insurance section.
What does a year of tirzepatide cost?
The same twelve months of the weekly injection can be paid for three ways. These are catalog prices before the new-patient welcome offer, and they assume twelve continuous months of treatment with no change of medication.
| How you pay | Payments in the year | Per month | Twelve months |
|---|---|---|---|
| Monthly | 12 × $399 | $399 | $4,788 |
| 3-month packages | 4 × $1,125 | $375 | $4,500 |
| 6-month packages | 2 × $2,199 | $367 | $4,398 |
Reading the table. Each step up in package length lowers the year's total and raises what you pay at any one time. Monthly asks the least of you at checkout and the most over the year. The 6-month package is the reverse. The 3-month package sits between them, and it is the natural step for someone who wants a lower monthly figure without committing half a year at once.
Adding lab work. One comprehensive panel at the start, assuming no repeat panels in the year, adds $199: on 6-month packages the year then comes to $4,597; paid monthly, $4,987.
The capsule. Oral tirzepatide has no packages, so its year is simply $4,788, paid monthly.
A package is paid up front and commits you to that supply. Cancellation terms for each option are shown at checkout; the pricing and insurance FAQ covers billing dates.
Tirzepatide or semaglutide: the price difference only
This section compares prices. It says nothing about which medication works better or suits you; that is a clinical decision made with your clinician, based on your history, labs and response.
Both are compounded weekly injections at ACT 2, both are priced the same at every dose, and both come in 3- and 6-month packages. Tirzepatide costs more at every level.
| Semaglutide or tirzepatide injection | Semaglutide | Tirzepatide |
|---|---|---|
| One month, paid monthly | $299 | $399 |
| Per month on a 6-month package | $258 | $367 |
| A year, paid monthly | $3,588 | $4,788 |
| A year, two 6-month packages | $3,098 | $4,398 |
Lab work is the same $199 a panel whichever you take. The semaglutide cost page sets out the semaglutide side in full.
Tirzepatide cost without insurance, and with it
ACT 2 is direct-pay and does not bill insurance, Medicare or Medicare Advantage. Coverage matters only if it could get you a branded tirzepatide product, and sometimes that route is less expensive.
Medicare, in brief. Part D excludes drugs used for weight loss by statute, with room for coverage when a GLP-1 is prescribed for another medically accepted indication. Medicare lists moderate-to-severe sleep apnea among the conditions where a Part D plan might cover a GLP-1. From July 1, 2026 to December 31, 2027, the Medicare GLP-1 Bridge gives eligible enrollees certain branded GLP-1s for weight reduction at a fixed copayment, with prior authorization. For tirzepatide, only the Zepbound KwikPen is named; single-dose Zepbound vials and pens are excluded, and compounded tirzepatide is not included. The semaglutide cost page explains the Medicare rules in full.
Commercial insurance. Coverage varies by plan and by year, and a drug on your formulary still usually sits behind prior authorization and the plan's own criteria.
Manufacturer self-pay. Eli Lilly sells Zepbound directly to self-pay patients through LillyDirect, where the self-pay price is listed by strength. We do not quote it here because it changes. Compare its current figure for the strength you would start on with the price here before you decide. A prescription is required, and a prescriber's visit is priced separately from the medication.
The branded route through your own coverage. If your commercial plan covers a branded GLP-1 for you, fill it that way. The Weight Loss Program Membership is $75 a month for clinical oversight, monitoring and plan review around it; your own pharmacy bills you for the drug.
Why compounded tirzepatide is priced differently from Zepbound
The tirzepatide prescribed through ACT 2 is compounded by a licensed pharmacy. It is not FDA-approved, and it is not the same as, equivalent to or interchangeable with Zepbound, Mounjaro or any branded product. The FDA states that it does not review compounded drugs for safety, effectiveness or quality before they are marketed. The two prices therefore describe two different kinds of product; the compounded tirzepatide versus Zepbound page sets out the differences.
What changes the number
- How you pay. Monthly, 3-month or 6-month packages, as in the year table.
- Form. The capsule is monthly only.
- Lab work. $199 per comprehensive panel.
- The welcome offer. New patients get 10% off the first order through the welcome offer; it does not apply to lab panels or to branded medication billed by your own pharmacy.
- Switching medication. Moving between tirzepatide and semaglutide changes the monthly price, as the comparison above shows.
Frequently asked questions
Compounded tirzepatide costs $399 a month at ACT 2 as a weekly injection or $399 as a daily capsule, with the clinician's care and the medication included. The injection is also sold as a 3-month package at $375 a month or a 6-month package at $367 a month. The price is the same at every dose. Lab work is priced separately.
A year of the tirzepatide injection costs $4,788 paid monthly, $4,500 as four 3-month packages, or $4,398 as two 6-month packages, assuming twelve continuous months at catalog prices before the welcome offer. One comprehensive lab panel at the start adds $199. The oral capsule is monthly only.
Yes, at ACT 2 compounded tirzepatide costs more than compounded semaglutide: $399 against $299 a month, and $4,398 against $3,098 for a year on 6-month packages. That is a price comparison only. Which medication suits you is a clinical decision based on your history, labs and response, not on price.
Without insurance, compounded tirzepatide at ACT 2 costs the published price: $399 a month, or less per month on a package. ACT 2 is direct-pay and does not bill insurance or Medicare, so the price is the same whatever coverage you have. If your plan covers a branded tirzepatide product, that route may cost you less for the medication.
Part D excludes drugs used for weight loss by statute, though a plan might cover a GLP-1 for another medically accepted indication, such as moderate-to-severe sleep apnea. From July 2026 to December 2027, the Medicare GLP-1 Bridge covers certain branded products for eligible enrollees, including the Zepbound KwikPen, with prior authorization. Compounded tirzepatide is not included, and ACT 2 does not bill Medicare.
No. Compounded tirzepatide is prepared by a licensed pharmacy, is not FDA-approved, and is not equivalent to or interchangeable with Zepbound or Mounjaro. Branded tirzepatide is FDA-approved and priced by its manufacturer, which lists self-pay prices by strength on LillyDirect. If your insurance covers a branded product, the Weight Loss Program Membership at $75 a month covers the clinical care around it.
Where this fits in your plan
Settle the coverage question first. If Medicare or your plan covers a branded GLP-1 for you, that is usually the less expensive route for the medication. If nothing is covered, the year table above plus lab work is the whole cost. Whether tirzepatide is right for you at all is a clinical decision, made at your assessment.
We measure first. Then we act.
References
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge coverage and eligibility). Centers for Medicare & Medicaid Services. https://www.medicare.gov/coverage/weight-loss-drugs
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. CMS, 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- Centers for Medicare & Medicaid Services. Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program… (CMS-4208-P), fact sheet. CMS, November 2024. https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription
- HealthCare.gov. Prior authorization (glossary). U.S. Centers for Medicare & Medicaid Services. https://www.healthcare.gov/glossary/prior-authorization/
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Eli Lilly and Company. LillyDirect: Zepbound self-pay and pharmacy options (manufacturer's official page). https://www.lilly.com/lillydirect/zepbound
- Back toPricing
- Tirzepatide injectionA dual GLP-1 and GIP receptor agonist that supports appetite regulation and weight management.Read
- Oral tirzepatideA needle-free oral form of tirzepatide, acting on the GLP-1 and GIP pathways.Read
- Compounded tirzepatide vs ZepboundZepbound and Mounjaro are one drug with two labels. Where compounded tirzepatide sits after the 2026 FDA action, and what to ask before you fill it.Read
- Semaglutide costCompounded semaglutide at ACT 2 is $299 a month with care included, or $258/mo on a 6-month package. Same price at every dose.Read
- Pricing and insurance FAQWhat ACT 2 Health costs, what each price includes, whether insurance is accepted, how HSA and FSA work, billing cadence, cancellation and shipping.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Prices shown are current catalog prices and are confirmed at your eligibility review; the price comparison with semaglutide is a comparison of cost only, not of effectiveness.